A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy Siming Li # 1 , Jinchang Wei # 1 , Huayan Xu 1 , Xiaowen Wu 1 , Juan Li 1 , Li Zhou 1 , Xieqiao Yan 1 , Bixia Tang 2 , Lu Si 2 , Chuanliang Cui 2 , Zhihong Chi 2 , Jun Guo 1 , Xinan Sheng 3,World J Urol .,43(1):206.

Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China Siming Li 1 , Yanxia Shi 2 , Haiying Dong 3 , Hongqian Guo 4 , Yu Xie 5 , Zhongquan Sun 6 , Xiaoping Zhang 7 , Eric Kim 8 , Jun Zhang 9 , Yue Li 9 , Chenming Xu 9 , Haishan Kadeerbai 9 , Sue Lee 10 , Seema Gorla 10 , Jun Guo 1 , Xinan Sheng 1,Cancer Med .,13(21):e70368

An iodine-labelled Antibody-drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma Ya'nan Ren 1 , Teli Liu 2 , Siming Li 3 , Xiaokun Ma 2 , Lei Xia 2 , Pei Wang 1 , Qian Guo 1 , Yuan Yao 2 , Xingguo Hou 2 , Xi'nan Sheng 4 , Hua Zhu 5 , Zhi Yang 6,Int J Pharm .,651:123756.

Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis Siming Li # 1 , Xiaowen Wu # 1 , Xieqiao Yan 1 , Li Zhou 1 , Zhihong Chi 2 , Lu Si 2 , Chuanliang Cui 2 , Bixia Tang 2 , Lili Mao 2 , Bin Lian 2 , Xuan Wang 2 , Xue Bai 2 , Jie Dai 2 , Yan Kong 2 , Xiongwen Tang 3 4 , Hui Feng 3 4 , Sheng Yao 3 4 , Keith T Flaherty 5 , Jun Guo 6 , Xinan Sheng 6,J Immunother Cancer .,10(2):e004036.